We propose that glycogen synthase kinase-3 (GSK3) plays a leading role in the cascade of events that culminate in AD as this kinase is involved in the mechanisms underlying learning and memory, in the hyper-phosphorylation of tau, in the increased production of Aβ from APP and also in local cerebral inflammatory responses. Here, MAPT is linked to Alzheimer disease.